Edition:
India

People: Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

9.17USD
11:00pm IST
Change (% chg)

$-0.39 (-4.08%)
Prev Close
$9.56
Open
$9.56
Day's High
$9.69
Day's Low
$8.86
Volume
13,773
Avg. Vol
55,303
52-wk High
$13.09
52-wk Low
$5.36

Auchincloss, Thomas 

Mr. Thomas G. Auchincloss Jr. serves as Independent Director of the Company. Mr. Auchincloss has served as a member of our Board since December 2014. Since September 2013, Mr. Auchincloss has served as Managing Member at Counterpoint Trading Company, LLC, a private investment firm. From August 2007 to September 2013, Mr. Auchincloss was self-employed in private investing. From May 2005 to August 2007, Mr. Auchincloss worked as Chief Financial Officer of Metabolix, Inc., a public biomaterials company. Prior to that, Mr. Auchincloss served as a consultant with Metabolix from April 2002 to May 2005, providing business development, financial and strategic consulting services. From 1994 to 2001, Mr. Auchincloss served in a variety of positions at Vertex Pharmaceuticals Incorporated, a pharmaceutical company, most recently as Vice President, Finance and Treasurer. Mr. Auchincloss received a B.S. in Business Administration from Babson College and an M.B.A. in Finance from the Wharton School. We believe that Mr. Auchincloss’ financial and industry experience, including his experience as the chief financial officer of a publicly traded biomaterials company, make him a key contributor to our Board.

Basic Compensation

Total Annual Compensation, USD 57,733
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 74,074
Fiscal Year Total, USD 131,807

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Aldrich

157,592

Roger Tung

2,772,350

Marc Becker

1,887,420

Nancy Stuart

1,908,030

James Cassella

1,695,040

Jeffrey Munsie

--
As Of  31 Dec 2019